National Bank of Canada’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

National Bank of Canada’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,000	Closed	-$1.81K	–	2929
2023 Q2	$1.81K	Hold	1,000	–	–	﹤0.01%	2486
2023 Q1	$1.32K	Hold	1,000	–	–	﹤0.01%	2493
2022 Q4	$1.69K	Hold	1,000	–	–	﹤0.01%	2520
2022 Q3	$2K	Hold	1,000	–	–	﹤0.01%	2558
2022 Q2	$3K	Hold	1,000	–	–	﹤0.01%	2571
2022 Q1	$7K	Hold	1,000	–	–	﹤0.01%	2491
2021 Q4	$16K	Buy	+1,000	New	+$11.6K	﹤0.01%	2223

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

National Bank of Canada's PRDS Position: Q3 2023 in Review

National Bank of Canada sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 1,000 shares — an estimated $1.81K sold.

National Bank of Canada first reported a position in PRDS in Q4 2021 and held it in 7 quarters. The position peaked at $16K in Q4 2021. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

National Bank of Canada reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
National Bank of Canada sold 1,000 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $1.81K.
National Bank of Canada first reported a position in Pardes Biosciences, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
National Bank of Canada's Pardes Biosciences, Inc. Common Stock position peaked at $16K in Q4 2021.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on National Bank of Canada's 13F filing for Q3 2023, filed 10 Oct 2023.